|
Market Closed -
NSE India S.E.
10:05:08 13/11/26 pm AEDT
|
5-day change | 1st Jan Change | ||
| 2,640.00 INR | -0.74% |
|
+1.93% | +29.72% |
| 09/11 | Acucort signs exclusive agreement for Zeqmelit in Canada - launch expected in 2028 | FW |
| 06/11 | Glenmark Pharmaceuticals Limited, Q2 2027 Earnings Call, Nov 06, 2026 |
Chart: Technical Analysis
NSE India S.E.INR
| Markets | Quality | ||
|---|---|---|---|
NSE India S.E.
| GLENMARK | Delayed | |
Bombay S.E.
| GLENMARK | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bullish |
| Resistance | 2,677.2 | 2,677.2 | 2,793.18 |
| Spread/Res. | -1.39% | -1.39% | -5.48% |
| Spread/Supp. | +11.31% | +11.31% | +15.64% |
| Support | 2,371.7 | 2,371.7 | 2,282.9 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- GLENMARK Stock
- Charts Glenmark Pharmaceuticals Limited
Select your edition
All financial news and data tailored to specific country editions
